<DOC>
	<DOCNO>NCT00828100</DOCNO>
	<brief_summary>The primary objective study compare performance investigational fluid Rapid Influenza Test BinaxNOW® Influenza A &amp; B Test detect influenza type A influenza type B .</brief_summary>
	<brief_title>Comparison Fluid Rapid Influenza BinaxNOW Influenza A &amp; B</brief_title>
	<detailed_description>The primary objective study compare performance investigational fluID Rapid Influenza Test BinaxNOW® Influenza A &amp; B Test detect influenza type A influenza type B , respect fresh nasal wash / aspirate specimen collect patient present sign symptom influenza-like illness ( ILI ) . Specimens evaluate study enrol concurrent clinical study per protocol FLU-05 , entitle `` Prospective Evaluation fluID Rapid Influenza Test '' . All subject enrol FLU-05 study consent sample use future investigation involve fluID Test . This study conduct 2008-2009 influenza season North America Hong Kong , anticipated run November 2008 May 2009 . Should influenza season conclude North America Hong Kong prior attainment minimum target enrollment specify FLU-05 study , study site Australia also enlist order enroll subject ; case , enrollment continue 2009 influenza season country , anticipated run May October , 2009 .</detailed_description>
	<mesh_term>Influenza , Human</mesh_term>
	<criteria>1 . Male female subject age ; 2 . Subjects present investigative site within 4 day symptom onset , : Fever ≥ 38.0°C ( 100.4°F ) take orally , ≥ 38.5°C ( 101.2°F ) take rectally ; selfreported history fever feel feverish ( include fever control medication ) absence document fever ; One respiratory symptom influenzalike illness may include follow : Sore throat Runny stuffy nose Cough One constitutional symptom influenzalike illness may include follow : Myalgia ( ache pain ) Headache Fatigue 3 . Subjects ( parent/guardian ) willing able provide inform consent ; 4 . Subjects must enrol Arm 3 FLU05 clinical study . Written subject inform consent study protocol must obtain prior study enrollment . Each subject ( parent guardian ) must personally sign date Subject Informed Consent Form prior his/her participation clinical study . 1 . Subjects present least three symptom influenzalike illness outline . 2 . Subjects receive influenza antiviral medication investigational influenza drug treatment within previous 30 day study enrollment . 3 . Subjects ( child adult ) obtain aspirate sample contraindicate possible . 4 . Subjects medical condition prevents nasal wash aspirate sample obtain . 5 . Active duty military personnel ( participate military study site ) . 6 . Subjects ( parent/guardian ) unwilling unable provide inform consent .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2009</verification_date>
</DOC>